We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Identification and quantification of micro–nano-plastics in polypropylene-bottled injections
AI summary Read the abstract
Researchers examined 16 batches of intravenous (IV) fluids packaged in polypropylene plastic bottles and found microplastic and nanoplastic particles in all of them, with concentrations reaching up to 10 million particles per milliliter. This is the first study to confirm that patients receiving IV infusions are being directly exposed to microplastics entering their bloodstream, though whether this causes harm remains to be studied.
Micro-nano-plastic (MNP) particles (p) in the environment can enter the human body and pose a potential threat to human health. However, it is unknown whether these substances are present in polypropylene (PP) plastic-bottled injections, which are used as high-frequency intravenous infusions to treat diseases. Therefore, the objective of this study was to identify and quantify insoluble MNP particles in 16 batches of injectable formulations within the validity period. Primarily, ethylene-propylene copolymer or P(E-P) micro-plastic (MP) particles (2-10 μm, 216 p/mL) were identified by micro-Raman spectroscopy, and nano-particles (<50 nm, 2.1 × 104 p/mL) similar to PP containing only carbon were detected by scanning electron microscopy-energy-dispersive X-ray spectroscopy (photoelectron). Furthermore, P(E-P) MP particles (1 × 103 to 1 × 105 ng/L) from the injections were enriched on the GF-B filter, and PP or P(E-P) nano-plastic (NP) particles (1 × 103 to 4 × 104 ng/L) enriched on the alumina film were detected by pyrolysis-gas chromatography/mass spectrometry. Finally, the total insoluble particles in injections were 6 × 104 to 1 × 107 p/mL (0.02-100 μm). Our findings are the first to identify and quantify MNPs in PP-bottled injections. Considering that they can enter the blood circulation, so whether cause disease remains to be investigated.
More Papers Like This
Health Risks from Microplastics in Intravenous Infusions: Evidence from Italy, Spain, and Ecuador
AI summary Read the abstract
Researchers analyzed intravenous (IV) fluid bags and bottles from Italy, Spain, and Ecuador and found microplastics in nearly all samples, with plastic bags containing up to 299 particles per liter. This is concerning because IV fluids deliver microplastics directly into the bloodstream, bypassing the body's natural barriers, and some brands showed concentrations high enough to pose clinical risk.
Hidden hazards: microplastics in intravenous admixtures and their path into the body
AI summary Read the abstract
This study investigated microplastic contamination in intravenous (IV) fluid bags used in hospitals, finding that prolonged storage in plastic containers leads to microplastic particles leaching into the solution. This means patients receiving IV treatments may be exposed to microplastics that enter the bloodstream directly, bypassing the body's natural barriers. The findings highlight an overlooked route of microplastic exposure in medical settings that needs further investigation.
Factors affecting micro(nano)plastic release during intravenous therapy: Direct blood exposure.
AI summary Read the abstract
This study systematically evaluated factors affecting micro(nano)plastic (MNP) release from medical infusion products during intravenous therapy. Results indicated that MNPs are released into IV fluid at measurable levels, potentially delivering plastic particles directly into the bloodstream of patients.
Microplastic injection? Identification and quantification of plastic particles in medical injections
AI summary Read the abstract
Scientists discovered that medical injection solutions (saline and glucose) sold in China contain an average of 895 microplastic particles per kilogram, with some samples reaching 1,840 particles. Unlike microplastics ingested through food, these particles enter the bloodstream directly through IV injection, bypassing the body's digestive barriers. This reveals a previously unrecognized pathway for microplastic exposure that could pose unique health risks for hospitalized patients.
Micro(nano)plastics (< 4 μm): An important but ignored concern during intravenous infusion
AI summary Read the abstract
Researchers found that common IV bags, tubes, and syringes release thousands of tiny plastic particles directly into the bloodstream during routine medical treatments. The particles, smaller than 4 micrometers, included types like PVC and polypropylene and were found in nearly all tested infusion products. This is a significant finding because it identifies a previously overlooked source of microplastic exposure that bypasses the body's natural barriers entirely.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.